Trial Profile
Special investigation of J Zoloft [sertraline] for panic disorder patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2021
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Panic disorder
- Focus Adverse reactions
- Sponsors Pfizer
- 11 Oct 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 22 Aug 2011 Planned end date changed from 1 Nov 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.